Clinical Trials Logo
  1. Home
  2. Sepsis
  3. NCT02738164
  4. Details
NCT02738164 Clinical Trial

SEPSIS 3 Critera for Risk Stratification in Emergency Patients

Sepsis Clinical Trial

— SCREEN  

Official title:
Validation of the SEPSIS-3 Criterion for Sepsis and Septic Shock in the Emergency Department

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT02738164
Other study ID # SCREEN_SFMU
Secondary ID
Status Completed
Phase N/A
First received April 2, 2016
Last updated July 17, 2016
Start date May 2016
Est. completion date July 2016

Study information
Verified date July 2016
Source Societe Française de Medecine d'urgence
Contact n/a
Is FDA regulated No
Health authority France: Committee for the Protection of Personnes
Study type Observational

Clinical Trial Summary

Investigators aim to evaluate the SEPSIS 3 criterion for "sepsis" and "septic shock" in a prospective manner.

Investigators will evaluate qSOFA performances and other SEPSIS 3 criterion in a population of emergency patients with infection

Recruitment information / eligibility
Status Completed
Enrollment 879
Est. completion date July 2016
Est. primary completion date July 2016
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Adult that present to the emergency department

- Diagnosis of infection by the treating emergency physician

Exclusion Criteria:

- Refuse to participate

- pregnancy

- prisoner

- Low acuity infection (localised, not requiring general treatment, without any abnormal vital parameters)

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

Locations
Country Name City State
Belgium St Luc Bruxelles
France CHU Angers Angers
France CHIPO Beaumont s Oise
France Avicenne Bobigny
France Saint Camille Bry sur Marne
France Dijon Dijon
France Grenoble Grenoble
France Longjumeau Longjumeau
France Lyon Lyon
France Princess Grace Monaco
France Nancy Nancy
France Nice Nice
France Ambroise Paré Paris
France Bichat Paris
France Cochin Paris
France HEGP Paris
France Lariboisière Paris
France Pitie-salpetriere Paris
France Saint-Antoine Paris
France St Louis Paris
France Tenon Paris
France Strasbourg Strasbourg
France Toulouse Toulouse
France Tours Tours
France Vienne Vienne
Spain Clinic hospital Barcelona Barcelona
Switzerland CHUV Lausanne

Sponsors (1)
Lead Sponsor Collaborator
Societe Française de Medecine d'urgence

Countries where clinical trial is conducted

Belgium,  France,  Spain,  Switzerland, 

Outcome
Type Measure Description Time frame Safety issue
Primary In hospital mortality 30 days No
Secondary admission in ICU 30 days No
Secondary length of ICU stay more than 72 hours 30 days No
Secondary Length of hospital stay 30 days No
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05095324 - The Biomarker Prediction Model of Septic Risk in Infected Patients
Completed NCT02714595 - Study of Cefiderocol (S-649266) or Best Available Therapy for the Treatment of Severe Infections Caused by Carbapenem-resistant Gram-negative Pathogens Phase 3
Completed NCT03644030 - Phase Angle, Lean Body Mass Index and Tissue Edema and Immediate Outcome of Cardiac Surgery Patients
Completed NCT02867267 - The Efficacy and Safety of Ta1 for Sepsis Phase 3
Completed NCT04804306 - Sepsis Post Market Clinical Utility Simple Endpoint Study - HUMC
Recruiting NCT05578196 - Fecal Microbial Transplantation in Critically Ill Patients With Severe Infections. N/A
Terminated NCT04117568 - The Role of Emergency Neutrophils and Glycans in Postoperative and Septic Patients
Completed NCT03550794 - Thiamine as a Renal Protective Agent in Septic Shock Phase 2
Completed NCT04332861 - Evaluation of Infection in Obstructing Urolithiasis
Completed NCT04227652 - Control of Fever in Septic Patients N/A
Enrolling by invitation NCT05052203 - Researching the Effects of Sepsis on Quality Of Life, Vitality, Epigenome and Gene Expression During RecoverY From Sepsis
Terminated NCT03335124 - The Effect of Vitamin C, Thiamine and Hydrocortisone on Clinical Course and Outcome in Patients With Severe Sepsis and Septic Shock Phase 4
Recruiting NCT04005001 - Machine Learning Sepsis Alert Notification Using Clinical Data Phase 2
Completed NCT03258684 - Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Sepsis and Septic Shock N/A
Recruiting NCT05217836 - Iron Metabolism Disorders in Patients With Sepsis or Septic Shock.
Completed NCT05018546 - Safety and Efficacy of Different Irrigation System in Retrograde Intrarenal Surgery N/A
Completed NCT03295825 - Heparin Binding Protein in Early Sepsis Diagnosis N/A
Not yet recruiting NCT06045130 - PUFAs in Preterm Infants
Not yet recruiting NCT05361135 - 18-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in S. Aureus Bacteraemia N/A
Not yet recruiting NCT05443854 - Impact of Aminoglycosides-based Antibiotics Combination and Protective Isolation on Outcomes in Critically-ill Neutropenic Patients With Sepsis: (Combination-Lock01) Phase 3